about
Lymphoma: immune evasion strategiesChemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.Interleukins in chronic liver disease: lessons learned from experimental mouse modelsKidney Dendritic Cells Become Pathogenic during Crescentic Glomerulonephritis with Proteinuria.Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injuryRole of gamma-delta T cells in liver inflammation and fibrosis.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.In situ vaccination for the treatment of cancer.Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.Eat more carrots? Dampening cell death in ethanol-induced liver fibrosis by β-caroteneNatural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation.Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice.Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccinationCyclic adenosine monophosphate-responsive element modulator alpha overexpression impairs function of hepatic myeloid-derived suppressor cells and aggravates immune-mediated hepatitis in miceAntitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint BlockadeKidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury
P50
Q28080705-289694CD-53E7-4DB3-8185-997EEF683DB7Q34070116-E9219D82-945C-4A23-9FB4-6141552146B0Q34154258-C47080D8-7EDC-4DC7-AD8A-05507F22C3D7Q34534894-0772DCF8-7399-4498-8C40-2E63DE3E4D9AQ35944978-0AF8D070-72D9-4321-ADB0-51165A40F5C3Q37170815-866D7E2B-1E0D-4F46-BFC0-0EB48B39C424Q38217236-D2785CA0-0833-4162-83E3-4AC28C2F8084Q38657642-2674CEB5-3465-4867-AEF7-3C88B65497FCQ38727470-24DD127F-9A5F-4116-B544-F42910C47A02Q40614034-D130C9A0-AF78-4F95-846D-5CFDF4A971B7Q41955783-582E23BE-39D1-4D35-902F-1EF1AB9D4AE8Q45921466-7C3B6F6A-BE69-437F-AE55-044D3C7FC04BQ50995002-7902355E-4400-4FEA-9F02-BDB4F0AF5981Q63101722-09A7005F-BA02-485A-BAD0-D296F75FA711Q85830613-62A18F28-C069-4B9E-84B6-44C82F88496EQ92376089-C9A4BE2C-3EC4-4CC1-B7A3-47F52349FDBAQ94348176-9D101870-EE48-40A7-89DA-7147BD0655B2
P50
description
investigador
@es
researcher
@en
name
Linda Hammerich
@en
type
label
Linda Hammerich
@en
prefLabel
Linda Hammerich
@en
P31
P496
0000-0003-0557-3927